Defining candidate drug characteristics for Long-QT (LQT3) syndrome (Q1942492): Difference between revisions
From MaRDI portal
Changed an Item |
Set OpenAlex properties. |
||
| (One intermediate revision by one other user not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.3934/mbe.2011.8.861 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2316627542 / rank | |||
Normal rank | |||
Revision as of 03:40, 20 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Defining candidate drug characteristics for Long-QT (LQT3) syndrome |
scientific article |
Statements
Defining candidate drug characteristics for Long-QT (LQT3) syndrome (English)
0 references
19 March 2013
0 references
cardiac arrhythmias
0 references
drug design
0 references
Markov models
0 references
optimization
0 references
